BSEBoard Meeting13 Aug 2026 · 13 Aug 2026, 04:50 pm
Pursuant to Reg. 30 of SEBI (LODR) Reg., 2015, we wish to inform you that in the meeting of the BOD of the Co held on Thursday, 13.08.2026 at 3.00 P.M. at the RO of the Co inter alia, transacted ....
Shree Pacetronix Ltd · 527005
✦ AI SummaryResults
Shree Pacetronix Ltd has announced the outcome of its 2nd board meeting for the financial year 2026-27, where the board considered and approved the unaudited financial results for the quarter ended June 30, 2026, and other matters including the reappointment of directors and the increase in remuneration of the Joint Managing Director.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Shree Pacetronix Ltd - 527005 - Board Meeting Outcome for Outcome Of The (2Nd/ 2026-27) Board Meeting Held On Thursday, 13Th August, 2026.
Attachments (1)
📄pdf
Download →
d6fd1902-cdc2-43c3-8360-9a0ea6de11bf.pdf
View document text
a c e t r a n 1 x
Shree Pacetranix Ltd.
Date: 13th August, 2026
General Manager-Listing,
BSE Limited,
Phiroze Jeejeebl1oy Towers,
Dalal Street,
Mumbai- 400001
Script Code - 527005; ISIN - INE847D01010
Subject: Outcome of the (2"d/ 2026-27) Board Meeting held on Thursday, 13th August, 2026.
Dear Sir/ Ma'am,
Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015, we
wish to inform you that in tl1e 02nd/2026-2027 n,eeting of the Board of Directors of the Company held on
Thursday, 13° 1 August, 2026 at 3.00 P.M. at the Registered office of the Company at Plot No. 15, Sector II,
Pithampur, Dist. Dhar (M.P.) - 454775, inter alia, trai1sacted the following items of business along with other
regular administrative and operatio11al businesses:
1. Considered & Approved the Unaudited Financial Result (Standalone & Consolidated) for the Quarter
ended 30th June, 2026.
2. Taken on record the Standalone and Consolidated Auditor's Limited Review report with an
unmodified opinion on the Financial Results for the Quarter ended 30th June, 2026.
3. Considered and approved Board's report along witl1 its annexures for the Financial Year ended 31st
March, 2026.
4. Approved the Notice of the 381 Annual General Meeting of the Co1npany to be held on T uesday,
29 1 September, 2026 at 01:00 P.M. (TST) at the registered office of the Company.
5. Finalization of cu t-off date and remote e-voting period for the ensuing AGM.
6. Fixed that tl"\e Register of members of the Company (for the purpose of the 38th Annual General
Meeting) will be closed from Wednesday, 23rd September, 2026 to Tuesday, 29th September, 2026
(both days i11clusive).
Jain
7. Appointed Mrs. ShraddJla (ACS-39488), Practicing Company Secretary as a scrutinizer of the
Company for tl1e purpose of e-voting facilities for th.e 33th Annual General Meeting of the Company.
8. Re-appointed Mr. Akash Sethi (DIN: 08176396), who holds office up to 13th August, 2027 as a Joint
Managing Director of the company for further period of three (3) consecutive years commencing
from 14th A ugus t, 2027 to 13th August, 2030, su bject to approval of the shareholders at the 38
Annual General Meeting. Further, he is no t debarred from holding the office of director pursuant to
any SEBI order or any other such authority (Brief Profile of Director is en closed as Annexure- A).
Celebrating 33 Years of Cardiac Pacing
Kolkata Adderss :
Factory & Regd. Office : Plot No. 15, Sector-II, CIN No. L33112MP1988PLC004317
Swastik Apartment, Ground Floor,
Pithampur, Dist. DHAR 454 775 (M.P.) INDIA
1 Sardar Sankar Road, Tolly Gunj,
Phone.: 07292 - 411105, Fax : 07292-400418 1
Kolkata - 700 026
Email : pacetronlx@hotmail.com
Ph. : (033} 2464 8931 Fax :2465 7753
TECHNOLOGY SERVING HUMANIT\ '
Web Site : www.pacetronix.com
9. Rc-appot11tcd M&. Manal1 Tongia (DIN: 09542172), who holds office up lo March, 2027 as a Non
23rd
ExL'Culive lr\dcpcnlle11t Direct:or of t}1e cornpany for a second term of five (5) consecutive yearc;
con1111encit1g tron1 24th Marci,, 2027 to 23rd Marcl1, 2032, subject to approval of the sl1areholders al the
3811 Annual General Meet111g Further, she fulfils tl1e criteria of independence as specified under the
Act ai,d SEBI Listing Regulations ar1d not liable lo retire by rotation (Brief Profile of Director is
e11closcd as Annexure- B).
10. Re-a1Jpointed Ms So1nya Cl1habra (DlN: 09597296), who holds offtce up to 5th May, 2027 as a Non
Executive Independent Director of tl1e company for a second term of five (5) consecutive years
commencing frotn 6th May, 2027 to 5th May, 2032, subject to approval of the sl1areholders at the 3gth
Annual General Meeting. Further, she fulfils the criteria of independence as specified under the Act
a11d SEBI Listing Regulations and not liable to retire by rotation (Brief Profile of Director is enclosed
as Annexure- C).
11. On recommcndabons received from the Nomination and Remuneration committee, the Board has
considered and approved the increase of remuneration payable to Mr. Akash Sethi (DIN: 08176396),
Joint Managing Director of the Company subject to the approval of the shareholders at the 3gth
Annual General Meeting of the company.
The Board l1as also discussed the other operabona1, financjal and administrative matters in detail
and passed tl1e necessary resolutio11s.
P. M •
i6 : 30
The Meeting of the Board of Directors commenced at 03:00 P.M. aI\d concluded at
You are requested to please take tl1e same on record.
Thanking you.
Yours Faithfully,
For SHREE PACETRONIX LIMITED
CIN: L33112MP1988PLC004317
i> tAC~),
.2.. .
f.lJ
RUPA LI AH IRE ~
COMPANY SECRETARY
ANNEXURE-A
Disclosure of information pursuant to Regulatio11 30 of the Securities and Exchange Board of India
(Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended ('Listing
Regulations') read witl1 SEBI Master Circular No. H0/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated
January 30, 2026 ('SEBI Circular');
Sr. No.
Details of events that needs to be Information of such event(s)
provided
Name of tl'\e Director Mr. Akash Sethi 'DIN-08176396.
Reason for Change viz. appointment, Revised the tenure of Mr Akash Sethi (DIN. 08176396)
resignation, removal, death or as Joint Managing Director of the Company upto 13th
other,'\rise
August,2030 due to the Re-avµointrnent
3 Date ef appe1ntrnent/ cessation / With effect from 141h August, 2027
reappointment (as applicable) & Term of appointment- 14th August, 2027 to 13th
Term of appointment August, 2030. (Subject to approval of shareholders of
the Company)
4. Brief Profile (in case of appointment) Mr. Akash Sethi, aged about 35 years is Joint
Managing Director of the Con1pany from 2018. He is
serving in capacity of Joint Managing Director of the
Con1pany and his tenure is expiring on 13th August,
2027 upon completion of 3 years of his appointment as
Joint Managing Director.
He is having more than 8 years of experience m•
industries and acquainted \Vtth thorough
knowledge of business of manufacturmg and
technicality of medical devices. He holds a Degree of
Master of Science under the Deparbnent of Electrical
and Computer Engineering from Carnegie tvlellon
University, USA by qualification.
5 Disclosure of relationsl1ips between Mr. Akash Sethi (DIN-08176396) is a Son of Mr. Atul
Directors (in case of appointment of Kumar Sethi (Managing Director)
Director
6. Informatio.n as required pursuant to Mr. Akash Setl1i Joint Managing Director, is not
BSE Circular No. debarred from holding the office of director by virtue
LISf/ COMP/ 14/2018-19 of any SEBI order or such other autl1ority.
A1111exure B
Disclosu1e of infom1ation pursttant to Regulation 30 of the Securities and Exchange Board of India
(Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended ('Listing
Regulations') read \-Vith SEBI Master Circular No. H0/49/14/14(7)2025-CFD-POD2/1/3762./2026 dated
January 30, 2026 ('SEBI Circular'):
Sr. No. Particulars Description
Name of the Director
Ms. Manali Tongia (DIN· 09542172)
2. Reason for change • Re-appointment as an Independent Director
VlZ.
appointment, resi• gnati• on, of the Company for a second term of five (5) consecutive
cessation, ren1oval, death or years, subject to the approval of the Members of the
otherwise
Company at the ensuing Annual General Meeting.
Date of appointment/ cessation / With effect from 24t11 March, 2027
reappointment (as applicable) & Term of appointment- 24Lh March, 2027 to 23rd March,
Term of appoint 2032. (Subject to approval of shareholders of the
ment
Company)
Brief profile (i.t1 case of Ms. Manali Tongia, aged 38 years, is a homemaker by
appoi11tment)
occupation. She brings a thoughtful and balanced
outlook to board deliberations. She is committed to
maintaining high standards of corporate governance
and ethical conduct m all her professional
engagements. She does not hold directorship in any
other company and has confirmed that she is not
disqualified from acting as a director under the
Companie
[Showing first 8,000 characters — download PDF for full document]